Euractiv (Advocacy Lab)
EU Perspectives
European Biotechnology Magazine
APM Market Access
EU PERSPECTIVES - Some pharmaceutical companies are openly warning that they could delay bringing their medicines to Europe. Solène Jouan is not willing to accept it. The policy officer at the European Patients' Forum believes such warnings place undue pressure on member states and already overstretched health systems. Ultimately, she argues, the...
EURACTIV - With global attention turning to expanding HIV prevention, Médecins Sans Frontières (MSF) is urging governments worldwide to ensure the twice-yearly drug lenacapavir becomes affordable and widely accessible. Its Belgian section made the appeal from Brussels during the 26th International AIDS Conference in Rio de Janeiro, calling on the...
EU PERSPECTIVES - Europe has learned to count the people extreme heat kills. It has barely begun to count what that heat does to the minds of those who live through it. Read more
EU PERSPECTIVES - Screens are not the main culprit behind Europe's youth mental health crisis. They merely amplify problems that already exist, and ignoring the crisis now could cost the EU €1.68tn over the next decade. Read more
